INTRODUCTION: Since the burden of COPD is increasing day by day and is a leading cause of mortality, it is important to have a prognostic marker for COPD. The well-known prognostic marker for COPD is the BODE score which includes 1) BMI 2) Degree OF Obstruction 3) Dyspnoea Scale 4) Exercise Capacity. Since the calculation Of BODE score is cumbersome and is not possible in sick patients, it is important to have a simple prognostic marker like Neutrophil- Lymphocyte Ratio(NLR) which can be easily obtained from a routine complete blood count which correlates well with that of BODE score. AIMS AND OBJECTIVES: 1.To assess whether Neutrophil-to-Lymphocyte ratio can be used to assess the severity of disease by comparing it with BODE score in ...
Background: Identifying patients with COPD at increased risk of poor outcomes is challenging due to ...
Eylem Acartürk Tunçay, Zuhal Karakurt, Emine Aksoy, Cuneyt Saltürk, Sinem Gungor, N...
C-reactive protein (CRP) and leukocyte count are standard tools for recognising inflammation in COPD...
Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised by poorl...
COPD is characterized by a pulmonary and systemic inflammatory process. Several authors have reporte...
AbstractChronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease of the lung. ...
Objectives: Chronic Obstructive Pulmonary Disease (COPD) is heterogeneous in nature. Acute exacerbat...
Emine Aksoy, Zuhal Karakurt, Sinem Gungor, Birsen Ocakli, İpek Ozmen, Elif Yildirim, Eylem Tuncay, M...
INTRODUCTION: This study was performed to determine whether neutrophil-lymphocyte ratio (NLR) optimi...
Introduction To examine the correlation of pulmonary functions and neutrophyle/lymphocyte ratio (NLR...
Abstract Background Neutrophil-to-lymphocyte ratio (NLR) is a biomarker of inflammation in chronic o...
Introduction Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammatory p...
BACKGROUND: COPD have widespread systemic effects and affects the quality of life. Classification o...
INTRODUCTION: COPD is a heterogenous disease with both pulmonary and extra pulmonary symptoms char...
Introduction: Chronic obstructive pulmonary disease (COPD) is a complex illness, associated with man...
Background: Identifying patients with COPD at increased risk of poor outcomes is challenging due to ...
Eylem Acartürk Tunçay, Zuhal Karakurt, Emine Aksoy, Cuneyt Saltürk, Sinem Gungor, N...
C-reactive protein (CRP) and leukocyte count are standard tools for recognising inflammation in COPD...
Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised by poorl...
COPD is characterized by a pulmonary and systemic inflammatory process. Several authors have reporte...
AbstractChronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease of the lung. ...
Objectives: Chronic Obstructive Pulmonary Disease (COPD) is heterogeneous in nature. Acute exacerbat...
Emine Aksoy, Zuhal Karakurt, Sinem Gungor, Birsen Ocakli, İpek Ozmen, Elif Yildirim, Eylem Tuncay, M...
INTRODUCTION: This study was performed to determine whether neutrophil-lymphocyte ratio (NLR) optimi...
Introduction To examine the correlation of pulmonary functions and neutrophyle/lymphocyte ratio (NLR...
Abstract Background Neutrophil-to-lymphocyte ratio (NLR) is a biomarker of inflammation in chronic o...
Introduction Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammatory p...
BACKGROUND: COPD have widespread systemic effects and affects the quality of life. Classification o...
INTRODUCTION: COPD is a heterogenous disease with both pulmonary and extra pulmonary symptoms char...
Introduction: Chronic obstructive pulmonary disease (COPD) is a complex illness, associated with man...
Background: Identifying patients with COPD at increased risk of poor outcomes is challenging due to ...
Eylem Acartürk Tunçay, Zuhal Karakurt, Emine Aksoy, Cuneyt Saltürk, Sinem Gungor, N...
C-reactive protein (CRP) and leukocyte count are standard tools for recognising inflammation in COPD...